- Topic
- Product safety
- Regulator
- FDA
- Published
- 28 October 2026
- For
- Imports
- Where it applies
- United States
From the notice
The Food and Drug Administration (FDA or Agency) is announcing the availability of the draft guidance titled "Electronic Submission Template for Investigational Device Exemption (IDE) Applications." FDA is issuing this draft guidance for sponsors submitting IDE applications to the Center for Devices and Radiological Health (CDRH) and Center for Biologics Evaluation and Research (CBER). It introduces those sponsors to the current publicly available resources and associated content developed toThe full text is at the source
Olive tells you which of these hit your products.
Olive reads every change like these against your own products, codes and trade lanes, whether you import, export or both, and drafts the update to your compliance program for your approval. Nothing changes without you.
Olivra lists official notices for information only. It is not legal advice, and Olive is not a lawyer or a licensed customs broker. The official text at the source is what counts.
More from FDA
- Safety
Individualized Human Genome Editing Products: Considerations for BLA Submission and Postapproval
FDAUnited StatesImports - Safety
Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ATEBRIOZ (Zilurgisertib)
FDAUnited StatesImports - Safety
Issuance of Priority Review Voucher; Rare Pediatric Disease Product; EMCITATE (Tiratricol)
FDAUnited StatesImports - Safety
Notice of Approval of Product Under Voucher: Material Threat Medical Countermeasure (MCM)
FDAUnited StatesImports